Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: A real-life study

INTRODUCTION: BNT162b2 (BioNTech and Pfizer) is a nucleoside-modified mRNA vaccine that provides protection against SARS-CoV-2 infection and is generally well tolerated. However, data about its efficacy, immunogenicity and safety in people of old age or with underlying chronic conditions are scarce....

Descripción completa

Detalles Bibliográficos
Autores principales: Meijide Míguez, Héctor, Montes García, Iñaki, Ochando Gómez, Miguel, García Merino, Isabel M., Cano, Emilio L., De La Torre, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SEGG. Published by Elsevier España, S.L.U. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986119/
https://www.ncbi.nlm.nih.gov/pubmed/37031072
http://dx.doi.org/10.1016/j.regg.2023.02.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986119/
https://www.ncbi.nlm.nih.gov/pubmed/37031072
http://dx.doi.org/10.1016/j.regg.2023.02.009

Ejemplares similares